The Detroit Tigers' ace Tarik Skubal was on a fast track to free agency history, but a curveball has just been thrown into that trajectory. The two-time defending American League Cy Young Award winner is set to undergo arthroscopic surgery on his left elbow to remove loose bodies, putting his record-setting contract hopes on hold.

While the team hasn't released a specific timetable, similar procedures have sidelined pitchers for two to three months. That means Skubal likely won't return until after the All-Star break in mid-July, and possibly not until the Aug. 3 trade deadline approaches. "I think the length of the rehab is probably just getting your spring training buildup again, getting your volume up," Skubal said. "But the procedure itself I think is pretty simple."

The financial stakes here are massive. After another dominant season in 2025, Skubal won an arbitration decision in February that awarded him a $32 million salary for this year—shattering all previous MLB arbitration records. At just 29 years old, he was widely viewed as a strong candidate to eclipse the current free-agent pitcher benchmark: the Dodgers' 12-year, $325 million deal with Yoshinobu Yamamoto signed in late 2023. Prior projections had Skubal's potential deal hovering around the $400 million mark.

This injury throws a major wrench into those expectations. Any potential suitor will be closely monitoring Skubal's health and performance when he returns before offering anything close to an unprecedented contract. Represented by super agent Scott Boras—known for his colorful commentary and fierce negotiations—the pitcher's market value will be fiercely defended. "The fans in Detroit want the Tigers to build the Tarik barrack," Boras quipped last fall, showcasing his trademark wordplay.

Skubal was also part of the U.S. team in the wildly successful World Baseball Classic, adding to his already stellar reputation. For now, Tigers fans and baseball analysts alike will be watching closely as this ace works his way back to the mound, with history—and a record payday—hanging in the balance.